Growing community of inventors

Chongqing, China

Fanxin Zeng

Average Co-Inventor Count = 14.73

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 4

Fanxin ZengWeibo Wang (4 patents)Fanxin ZengXingdong Zhao (4 patents)Fanxin ZengXianlong Wang (4 patents)Fanxin ZengYanxin Liu (4 patents)Fanxin ZengJing Sun (4 patents)Fanxin ZengZuwen Zhou (4 patents)Fanxin ZengTongshuang Li (4 patents)Fanxin ZengLihua Jiang (4 patents)Fanxin ZengLing Chen (4 patents)Fanxin ZengQiang Tian (4 patents)Fanxin ZengHaohan Tan (2 patents)Fanxin ZengZhifang Chen (2 patents)Fanxin ZengZhifu Li (2 patents)Fanxin ZengQihong Liu (2 patents)Fanxin ZengYue Rong (2 patents)Fanxin ZengQuan Yuan (2 patents)Fanxin ZengHailong Shi (2 patents)Fanxin ZengBo Fang (2 patents)Fanxin ZengFanxin Zeng (4 patents)Weibo WangWeibo Wang (38 patents)Xingdong ZhaoXingdong Zhao (19 patents)Xianlong WangXianlong Wang (13 patents)Yanxin LiuYanxin Liu (12 patents)Jing SunJing Sun (12 patents)Zuwen ZhouZuwen Zhou (12 patents)Tongshuang LiTongshuang Li (12 patents)Lihua JiangLihua Jiang (11 patents)Ling ChenLing Chen (10 patents)Qiang TianQiang Tian (7 patents)Haohan TanHaohan Tan (14 patents)Zhifang ChenZhifang Chen (10 patents)Zhifu LiZhifu Li (10 patents)Qihong LiuQihong Liu (9 patents)Yue RongYue Rong (8 patents)Quan YuanQuan Yuan (2 patents)Hailong ShiHailong Shi (2 patents)Bo FangBo Fang (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Shanghai Fochon Pharmaceutical Co., Ltd. (4 from 13 patents)


4 patents:

1. 10053449 - Quinazoline derivatives, compositions thereof, and use as pharmaceuticals

2. 10022374 - Certain protein kinase inhibitors

3. 9714235 - Quinazoline derivatives, compositions thereof, and use as pharmaceuticals

4. 9556171 - Certain protein kinase inhibitors

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/8/2026
Loading…